The global burn care centers market size was valued at USD 24.5 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 3.2% from 2020 to 2027. The increasing number of burn-related emergency department (ED) visits and growing hospital admissions of patients majorly for second degree or partial thickness are among the key factors propelling the market growth. Among all the burn cases, second-degree or partial thickness has been reported to be the most frequent burn severity for both related ED visits accounting for approximately 56.4 percent and inpatient stays accounting for 51.9 percent of overall burn cases in the U.S. Moreover, the majority of related ED visits and inpatient stays were reported to be accidents caused by steam and hot liquids.
Approximately two-thirds of the related deaths caused due to fire occur in Southeast Asian countries. The growth is mainly attributed to increasing emergency department (ED) visits for burn and growing in-hospital admissions necessitating long-term care. According to the National Health Service (NHS), U.K., in August 2018, it has been reported that the number of emergency admissions in the U.K. has grown by about 42% during the past twelve years, with burns accounting for approximately 2% of the overall admissions. This factor is projected to boost the market growth over the forecast period.
Burns are majorly caused by heat, electricity, sunlight, chemicals, and nuclear radiation. Approximately 265,000 deaths are occurring from burn-related injuries every year worldwide. The patients with burns covering more than 20 percent of their body, i.e., Total Body Surface Area (TBSA) >20 percent, are reported to be fatal. However, over the last ten years, the incidence of related deaths has declined by approximately 50 percent and the patients with TBSA >90 percent have reported increased survival rate after opting for appropriate treatment.
Although there has been a tremendous improvement in prognoses and treatment options for burn-related injuries, the incidence of such injuries majorly in Southeast Asian countries, and the cost of treatment in America and European nations remain high. The Centers for Disease Control and Prevention (CDC) has reported that about 338,000 patients in the United States have received emergency medical treatment for burns, followed by approximately 45,000 in-patient stays in 2016. The estimated treatment cost associated with such injuries in the United States was valued at approximately US$ 7.1 billion in 2016.
Amid the ongoing COVID-19 pandemic, burn care facilities are struggling hard to maintain a balance between their contributions to the pandemic response and upholding the ongoing burn care in an ethical and safe manner. In the U.S., with the increasing number of COVID-19 patients, the inpatient hospital organizations are allocating an additional space in a sequential manner starting with trauma surgical ICUs, followed by post-anesthesia care unit (PACU) and burn/pediatric ICUs.
The Edwards Lifesciences Foundation is a sponsor of the Valvular Disease Education Center and Ambassador Program, American Heart Association in the U.S. The Heart Valve CareLine is a free patient hotline that provides professional assistance to patients. It also provides guidance on the insurance and reimbursement system. This initiative was funded by the Edwards Lifesciences Foundation.
In 2019, the in-hospital facilities segment held the largest share of 52.6% owing to the presence of the highest number of tertiary care hospitals with specialized in-hospital facilities. The majority of the countries in the Asia Pacific and the Middle East have been reported to account for a few standalone centers, which shifts the patient’s treatment preference towards in-hospital specialized facilities, thereby accounting for the largest revenue share as compared to standalone facilities present globally. For instance, in 2018, the U.S. generated the majority of the revenue for care owing to the presence of the highest number of 128 burn centers as compared to other countries. The sudden outbreak of COVID-19 significantly transformed healthcare delivery, impacting hospital services, infrastructure, and patient safety. The number of outpatient visits to burn centers has significantly decreased in the U.S., especially during the lockdown.
The standalone segment is expected to register the fastest growth rate of 4.3% over the forecast period. This is attributed to the increasing preference of patients for personalized care and value-based services as compared to the quantity-oriented services. Moreover, the increased bed availability for long-term care of victims in standalone facilities in comparison to in-hospital is another factor boosting the growth of the segment. Additionally, due to the premium quality of care offered by specialty doctors and nurses in the standalone centers leading to reduced infections, the majority of the patients prefer to choose these facilities for treatment. The outpatient in-person burn center appointments have been gradually reduced by 90.0% owing to reschedule that includes reconstruction and late burn effects and increasing tele-visits for the burn care mostly via pictures or with video-visits.
In 2019, wound debridement emerged as the largest application segment with a revenue share of 32.9%. The OTC pain medications and bandages segment, followed by skin graft, is expected to be the fastest-growing segment over the forecast period. Wound debridement treatment is the most common treatment procedure associated with burn-related emergency department (ED) visits. On average, approximately 25.0% of the ED visits cases and 38.0% of the in-patient stays are treated via wound debridement treatment procedure.
Additionally, the other frequent treatment procedures for related ED visits majorly include approximately 17.0% of the ED visits burn cases treated through splints, traction, and other wound care, followed by 16.0% of the patients requiring prophylactic vaccinations and inoculations. On average, the length of related inpatient stays is estimated to be twice as long as the general patient stays. Furthermore, the treatment cost for such injuries is more than twice as costly as treatment costs for general patient care.
The OTC pain medications and bandages segment is expected to grow at the highest rate over the forecast period due to the increased consumption of pain management drugs and wound dressing in partial and full-thickness cases. Followed by OTC pain medications and bandages, the skin graft treatment segment is expected to register robust growth due to high demand from hospital inpatient stays. Skin graft procedures are estimated to treat approximately 30 percent of inpatient stays. Moreover, one-third of related inpatient stays are due to accidents involving hot substances or fire, or explosives.
In 2019, the partial-thickness burns segment held the largest revenue share of 51.5%. The minor burns segment is expected to witness significant growth over the forecast period owing to the increasing incidence of minor burn injuries globally. Second-degree or partial thickness emerged as the most common burn severity for both related in-patient stays and ED visits. The growing need for long-term observation care for partial or full-thickness injuries resulted in the increased treatment cost and other indirect costs associated with the long-term stays, thereby propelling the market growth.
The minor burn injuries are potential enough to develop into chronic and acute wounds. In order to treat minor burns, the doctor needs to understand the interventions to properly heal wounds, which increases the overall patient visits to the hospital. Minor burns can also be treated using advanced or conventional wound dressings. For instance, collagen sheets have proved to be highly useful in minor burn treatment.
The full-thickness burns segment is expected to witness the fastest growth over the forecast period. Full-thickness injuries cover more than 15% of the patient’s body and usually require a longer time to heal. They are majorly caused by several external factors including electricity, chemicals, radiation, respiratory, and thermal causes. Skin grafts are widely used for the treatment of partial and full-thickness burns, aiding the fast healing of wounds. Among all the burn cases, second-degree or partial thickness has been reported to be the most frequent burn severity for both related ED visits accounting for approximately 56.4 percent and inpatient stays accounting for 51.9 percent of the overall burn cases in the U.S.
In 2019, the inpatient service type emerged as the largest segment with a revenue share of 73.2% and is expected to be the fastest-growing segment over the forecast period owing to the increasing number of hospital admissions for burn victims globally. Though the rate of inpatient stays in such cases is not increasing at a significant pace, even a few countries are witnessing a declining trend, the high costs associated with inpatient services are resulting in the largest revenue share of the segment.
Despite the decline in the number of hospital admissions and ED visits for burn in the majority of the countries, the market growth is expected to be significant due to high treatment costs associated with these service types. As per a study published by the WHO in 2018, countries including Australia, China, Israel, Netherlands, Bulgaria, Czech Republic, and the U.K. have reported an increase in the number of burn admissions. However, countries such as China, Hong, Kong, Canada, Singapore, Mexico, South Korea, Sweden, and the U.S. have witnessed a declining trend for burn incidences.
In 2019, North America accounted for the largest revenue share of 46.3%. The presence of standalone centers and well-established healthcare facilities, coupled with favorable reimbursement policies covering approximately 70% of the treatment cost and availability of advanced wound care treatments, is a key factor contributing to the market growth in developed economies. In addition, the adoption of personalized care and quality treatments, such as reconstructive surgery and wound debridement, is contributing to market growth.
Asia Pacific is anticipated to be the most lucrative market, expanding at the fastest CAGR of 4.3% during the forecast period. Emerging economies in the Asia Pacific such as India and China have been witnessing strong economic growth and healthcare expenditure. The growing disposable income of people in these countries is expected to increase the demand for burn treatment procedures in forecast years.
Centers are focusing on improvising their inpatient and outpatient services, such as advanced dressing options and complex wound management. In 2017, physicians at the U.S. Army Institute of Surgical Research Burn Center utilized a novel method of pain medication administration to patients in the burn ICU unit with an aim to reduce opioid addiction and other issues. Some prominent players in the global burn care centers market include:
Burn and Reconstructive Centers of America
Pediatric Burn Care Center (The General Hospital Corporation)
University of Rochester Medical Center
National Burn Center (India)
Chelsea & Westminster Hospital
North Bristol NHS Trust
The MetroHealth System
University of Washington Regional Burn Center
Report Attribute |
Details |
Market size value in 2020 |
USD 18.51 billion |
Revenue forecast in 2027 |
USD 23.09 billion |
Growth Rate |
CAGR of 3.2% from 2020 to 2027 |
Base year for estimation |
2019 |
Historical data |
2016 - 2018 |
Forecast period |
2020 - 2027 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2020 to 2027 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Facility type, treatment type, burn severity, service type, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Russia; China; India; Japan; Australia; South Korea; Mexico; Brazil; Argentina; South Africa; Saudi Arabia; UAE |
Key companies profiled |
Burn and Reconstructive Centers of America; Pediatric Burn Care Center (The General Hospital Corporation); University of Rochester Medical Center; National Burn Center (India); Chelsea & Westminster Hospital; North Bristol NHS Trust; The MetroHealth System; University of Washington Regional Burn Center |
Customization scope |
Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail of customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research, Inc. has segmented the global burn care centers market report on the basis of facility type, treatment type, burn severity, service type, and region:
Facility Type Outlook (Revenue, USD Million, 2016 - 2027)
In-hospital
Standalone
Treatment Type Outlook (Revenue, USD Million, 2016 - 2027)
Wound debridement
Skin graft
Traction, splints, wound Care
Respiratory intubation and ventilation
OTC pain medications and bandages
Blood transfusion
Prophylactic vaccinations and inoculations
Rehabilitation
Burn Severity Outlook (Revenue, USD Million, 2016 - 2027)
Minor Burns
Partial Thickness Burns
Full Thickness Burns
Service Type Outlook (Revenue, USD Million, 2016 - 2027)
Inpatient
Outpatient
Rehabilitation
Regional Outlook (Revenue, USD Million, 2016 - 2027)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Russia
Asia Pacific
Japan
China
India
Australia
South Korea
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
b. The global burn care centers market size was estimated at USD 24.5 billion in 2019 and is expected to reach USD 18.51 billion in 2020.
b. The global burn care centers market is expected to grow at a compound annual growth rate of 3.2% from 2020 to 2027 to reach USD 23.1 billion by 2027.
b. Wound debridement dominated the burn care centers market with a share of 35.2% in 2019. This is attributable to fact that wound debridement treatment is witnessed to be the most common treatment procedure associated with burn-related emergency department (ED) visits.
b. Some key players operating in the burn care centers market include Burn and Reconstructive Centers of America; Pediatric Burn Care Center (The General Hospital Corporation); University of Rochester Medical Center; National Burn Center (India); Chelsea & Westminster Hospital; and North Bristol NHS Trust.
b. Key factors that are driving the burn care centers market growth include the increasing number of burn-related emergency department (ED) visits and growing hospital admissions of patients majorly for second degree or partial thickness.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."